- Assessment of Patient Pain Experience during Intravitreal 27-Gauge Bevacizumab and 30-Gauge Ranibizumab Injection
-
Guler M, Bilgin B, Capkin M, Simsek A, Bilak S
- KMID: 2363758
- Korean J Ophthalmol.
- 2015 Jun;29(3):190-194.
- doi: 10.3341/kjo.2015.29.3.190
PURPOSE: To compare pain scores of patients during intravitreal 27-gauge bevacizumab and 30-gauge ranibizumab injection procedures. METHODS: Seventy eyes of 70 patients who had not previously undergone intravitreal anti-vascular endothelial growth... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Outcomes of Eyes with Submacular Hemorrhage Secondary to Age-related Macular Degeneration Treated with Anti-vascular Endothelial Growth Factor
-
Kim KH, Kim JH, Chang YS, Lee TG, Kim JW, Lew YJ
- KMID: 2363805
- Korean J Ophthalmol.
- 2015 Oct;29(5):315-324.
- doi: 10.3341/kjo.2015.29.5.315
PURPOSE: To evaluate the long-term outcomes of intravitreal anti-vascular endothelial growth factor (VEGF) monotherapy for patients diagnosed with submacular hemorrhage secondary to exudative age-related macular degeneration. METHODS: This retrospective, observational study... -
- CITED
-
- Close
- SHARE
-
- Close
